DeepCure
DeepCure is transforming the field of small-molecule drug discovery, by delivering better drugs in a faster and more affordable way.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD273m (Public information from Apr 2024)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
| N/A | N/A | - | |
* | $40.0m | Series A | |
* | $24.6m Valuation: $200m | Series A | |
| Total Funding | CAD88.1m | ||
Related Content
Recent News about DeepCure
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.